(0.21%) 5 533.25 points
(0.15%) 39 529 points
(0.24%) 19 975 points
(0.77%) $82.17
(-1.00%) $2.58
(-0.20%) $2 335.00
(-0.17%) $29.51
(0.55%) $1 007.40
(-0.49%) $0.929
(-0.62%) $10.61
(-0.25%) $0.789
(1.64%) $87.13
-0.65% £ 2 295.00
Live Chart Being Loaded With Signals
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions...
Stats | |
---|---|
Tagesvolumen | 4 613 |
Durchschnittsvolumen | 89 480 |
Marktkapitalisierung | 802.18M |
EPS | £0.120 ( Q2 | 2023-12-31 ) |
Nächstes Ertragsdatum | ( £0 ) 2024-09-02 |
Last Dividend | £10.29 ( 2024-03-21 ) |
Next Dividend | £0 ( N/A ) |
P/E |
109.29 (Sector) 0 (Industry) 0 |
ATR14 | £8.35 (0.36%) |
Volumen Korrelation
Craneware PLC Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Craneware PLC Korrelation - Währung/Rohstoff
Craneware PLC Finanzdaten
Annual | 2022 |
Umsatz: | £174.02M |
Bruttogewinn: | £148.44M (85.30 %) |
EPS: | £0.260 |
FY | 2022 |
Umsatz: | £174.02M |
Bruttogewinn: | £148.44M (85.30 %) |
EPS: | £0.260 |
FY | 2022 |
Umsatz: | £165.54M |
Bruttogewinn: | £142.37M (86.00 %) |
EPS: | £0.270 |
FY | 2021 |
Umsatz: | £75.58M |
Bruttogewinn: | £70.21M (92.89 %) |
EPS: | £0.482 |
Financial Reports:
No articles found.
Craneware PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£12.88 (N/A) |
£10.19 (N/A) |
£0 (N/A) |
£0 (N/A) |
£12.74 (N/A) |
£10.29 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.969 | 2008-11-05 |
Last Dividend | £10.29 | 2024-03-21 |
Next Dividend | £0 | N/A |
Payout Date | 2024-04-15 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | £412.44 | -- |
Avg. Dividend % Per Year | 0.90% | -- |
Score | 4.47 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.29 | |
Div. Directional Score | 9.29 | -- |
Year | Amount | Yield |
---|---|---|
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £19.92 | 0.69% |
2020 | £21.19 | 0.89% |
2021 | £20.26 | 0.93% |
2022 | £22.36 | 0.93% |
2023 | £22.93 | 1.25% |
2024 | £10.29 | 0.60% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
21 Mar 2024 | £10.29 | 30 Nov -0001 | 22 Mar 2024 | 15 Apr 2024 |
23 Nov 2023 | £12.74 | 30 Nov -0001 | 24 Nov 2023 | 15 Dec 2023 |
23 Mar 2023 | £10.19 | 06 Mar 2023 | 24 Mar 2023 | 14 Apr 2023 |
24 Nov 2022 | £12.88 | 20 Sep 2022 | 25 Nov 2022 | 16 Dec 2022 |
24 Mar 2022 | £9.48 | 14 Mar 2022 | 25 Mar 2022 | 14 Apr 2022 |
25 Nov 2021 | £11.63 | 21 Sep 2021 | 26 Nov 2021 | 21 Dec 2021 |
18 Mar 2021 | £8.63 | 01 Mar 2021 | 19 Mar 2021 | 15 Apr 2021 |
19 Nov 2020 | £11.30 | 21 Sep 2020 | 20 Nov 2020 | 15 Dec 2020 |
19 Mar 2020 | £9.89 | 03 Mar 2020 | 20 Mar 2020 | 16 Apr 2020 |
28 Nov 2019 | £11.62 | 03 Sep 2019 | 29 Nov 2019 | 19 Dec 2019 |
14 Mar 2019 | £8.30 | 05 Mar 2019 | 15 Mar 2019 | 11 Apr 2019 |
08 Nov 2018 | £10.74 | 04 Sep 2018 | 09 Nov 2018 | 06 Dec 2018 |
29 Mar 2018 | £7.11 | 06 Mar 2018 | 03 Apr 2018 | 20 Apr 2018 |
09 Nov 2017 | £8.60 | 05 Sep 2017 | 10 Nov 2017 | 07 Dec 2017 |
30 Mar 2017 | £6.97 | 07 Mar 2017 | 31 Mar 2017 | 20 Apr 2017 |
10 Nov 2016 | £7.20 | 06 Sep 2016 | 11 Nov 2016 | 08 Dec 2016 |
17 Mar 2016 | £5.22 | 08 Mar 2016 | 18 Mar 2016 | 01 Apr 2016 |
19 Nov 2015 | £5.06 | 08 Sep 2015 | 20 Nov 2015 | 15 Dec 2015 |
26 Mar 2015 | £4.24 | 10 Mar 2015 | 27 Mar 2015 | 24 Apr 2015 |
13 Nov 2014 | £4.32 | 16 Sep 2014 | 14 Nov 2014 | 16 Dec 2014 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
DNA2.L | Dividend Royal | 2024-04-18 | Quarterly | 9 | 16.51% | 8.69 |
FAIR.L | Dividend Royal | 2024-05-30 | Quarterly | 9 | 10.77% | 8.67 |
MPLS.L | Dividend Royal | 2024-04-11 | Quarterly | 7 | 12.84% | 8.67 |
BGLF.L | Dividend Royal | 2024-05-02 | Quarterly | 9 | 10.03% | 8.50 |
SEPL.L | Dividend Royal | 2024-05-30 | Quarterly | 11 | 10.34% | 8.34 |
DNA3.L | Dividend Royal | 2024-04-18 | Quarterly | 12 | 14.16% | 8.31 |
DEC.L | Dividend Royal | 2024-08-29 | Quarterly | 8 | 59.83% | 7.91 |
AA4.L | Dividend Royal | 2024-04-11 | Quarterly | 9 | 12.37% | 7.88 |
IMB.L | Dividend Royal | 2024-08-22 | Quarterly | 28 | 7.10% | 7.51 |
FBH.L | Dividend Royal | 2024-05-02 | Annually | 22 | 11.26% | 7.46 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0515 | 1.500 | 8.97 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0278 | 1.200 | 9.07 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0623 | 1.500 | -0.419 | -0.628 | [0.1 - 1] |
payoutRatioTTM | 1.202 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 0.777 | 0.800 | -1.113 | -0.890 | [1 - 3] |
quickRatioTTM | 0.698 | 0.800 | -0.598 | -0.478 | [0.8 - 2.5] |
cashRatioTTM | 0.416 | 1.500 | 8.80 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.108 | -1.500 | 8.20 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 7.42 | 1.000 | 8.36 | 8.36 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.27 | 2.00 | 7.91 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.24 | 2.00 | 6.88 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.192 | -1.500 | 9.23 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.854 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.109 | 1.000 | 9.82 | 9.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.57 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.540 | 0.800 | 9.74 | 7.79 | [0.5 - 2] |
Total Score | 12.30 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 64.81 | 1.000 | 3.55 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0623 | 2.50 | -0.269 | -0.628 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.24 | 2.00 | 7.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.787 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.27 | 2.00 | 7.91 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.202 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 184.55 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.716 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 6.29 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Craneware PLC
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.